Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.
Drug Topics sister site Contemporary Pediatrics sat down with Abigail Donovan, MD, assistant professor of psychiatry at Massachusetts General Hospital in Boston to discuss brexpiprazole, which recently received a supplemental new drug application from the US Fod and Drug Administration for use in patients aged 13 to 17 years. She discussed what it brings to the table, the adverse effects it can cause, and who is likely to prescribe it.
This article originally appeared on Contemporary Pediatrics.
The Chronic Complications For Children With T1DM
May 30th 2023Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
Episode 1: Long Term Care and the "Unsung Health Care Heroes" of the Pandemic
June 17th 2020How can we care for our elderly during a pandemic? Pharmacists practicing in long term care settings discuss the changes and response from their facilities, plus insights on a potential treatment specific to older adults for COVID-19.
2 Clarke Drive
Cranbury, NJ 08512